A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors
- PMID:9397168
- DOI: 10.1021/jm960647n
A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors
Abstract
A novel technique for docking ligands to the beta 2-adrenergic receptor is described which exploits the domain structure of this class of receptors. The ligands (norepinephrine, an agonist; pindolol, a partial agonist; and propranolol, an antagonist) were docked into the receptor using the key conserved aspartate on helix 3 (D113) as an initial guide to the placement of the amino group and GRID maps (Goodford, P. J. J. Med. Chem, 1985, 28, 849) to identify the likely binding regions of the hydrophobic (and hydroxyl) moieties on the A domain (comprising of helices 1-5). The essence of the new approach involved pulling the B domain, which includes helices 6 and 7, away from the other domain by 5-7 A. During the subsequent minimization and molecular dynamics, the receptor ligand complex reformed to yield structures which were very well supported by site-directed mutagenesis data. In particular, the model predicted a number of important interactions between the antagonist and key residues on helix 7 (notably Leu311 and Asn312) which have not been described in many previous computer simulation studies. The justification for this new approach is discussed in terms of (a) phase space sampling and (b) mimicking the natural domain dynamics which may include domain swapping and dimerization to form a 5,6-domain-swapped dimer. The observed structural changes in the receptor when pindolol, the partial agonist, was docked were midway between those observed for propranolol and norepinephrine. These structural changes, particularly the changes in helix-helix interactions at the dimer interface, support the idea that the receptors have a very dynamic structure and may shed some light on the activation process. The receptor model used in these studies is well supported by experiment, including site-directed mutagenesis (helices 1-7), zinc binding studies (helices 2, 3, 5, and 6), the substituted cysteine accessibility method (helices 3, 5, and 7), and site-directed spin-labeling studies (helices 3-6).
Similar articles
- Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation.Rubenstein LA, Zauhar RJ, Lanzara RG.Rubenstein LA, et al.J Mol Graph Model. 2006 Dec;25(4):396-409. doi: 10.1016/j.jmgm.2006.02.008. Epub 2006 Mar 30.J Mol Graph Model. 2006.PMID:16574446
- Domain swapping in G-protein coupled receptor dimers.Gouldson PR, Snell CR, Bywater RP, Higgs C, Reynolds CA.Gouldson PR, et al.Protein Eng. 1998 Dec;11(12):1181-93. doi: 10.1093/protein/11.12.1181.Protein Eng. 1998.PMID:9930667
- Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.Bhattacharya S, Hall SE, Vaidehi N.Bhattacharya S, et al.J Mol Biol. 2008 Oct 3;382(2):539-55. doi: 10.1016/j.jmb.2008.06.084. Epub 2008 Jul 7.J Mol Biol. 2008.PMID:18638482
- Drug design strategies for targeting G-protein-coupled receptors.Klabunde T, Hessler G.Klabunde T, et al.Chembiochem. 2002 Oct 4;3(10):928-44. doi: 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5.Chembiochem. 2002.PMID:12362358Review.
- Genetic approaches to the determination of structure-function relationships of G protein-coupled receptors.Strader CD, Sigal IS, Dixon RA.Strader CD, et al.Trends Pharmacol Sci. 1989 Dec;Suppl:26-30.Trends Pharmacol Sci. 1989.PMID:2559516Review.
Cited by
- Modeling and active site refinement for G protein-coupled receptors: application to the beta-2 adrenergic receptor.Krystek SR Jr, Kimura SR, Tebben AJ.Krystek SR Jr, et al.J Comput Aided Mol Des. 2006 Jul-Aug;20(7-8):463-70. doi: 10.1007/s10822-006-9065-z. Epub 2006 Oct 13.J Comput Aided Mol Des. 2006.PMID:17054017
- Entropy and oligomerization in GPCRs.Thummer RP, Campbell MP, Dean MK, Frusher MJ, Scott PD, Reynolds CA.Thummer RP, et al.J Mol Neurosci. 2005;26(2-3):113-22. doi: 10.1385/JMN:26:2-3:113.J Mol Neurosci. 2005.PMID:16012184Review.
- Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.Li AH, Moro S, Forsyth N, Melman N, Ji XD, Jacobson KA.Li AH, et al.J Med Chem. 1999 Feb 25;42(4):706-21. doi: 10.1021/jm980550w.J Med Chem. 1999.PMID:10052977Free PMC article.
- Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modeling.Moro S, Deflorian F, Spalluto G, Pastorin G, Cacciari B, Kim SK, Jacobson KA.Moro S, et al.Chem Commun (Camb). 2003 Dec 21;(24):2949-56. doi: 10.1039/b303439a.Chem Commun (Camb). 2003.PMID:14703805Free PMC article.Review.
- Computational study on the different ligands induced conformation change of β2 adrenergic receptor-Gs protein complex.Bai Q, Zhang Y, Ban Y, Liu H, Yao X.Bai Q, et al.PLoS One. 2013 Jul 29;8(7):e68138. doi: 10.1371/journal.pone.0068138. Print 2013.PLoS One. 2013.PMID:23922653Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources